Human neutrophil elastase: Mediator and therapeutic target in atherosclerosis

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 6-7, 2008, Pages 1095-1100

  Henriksen, Peter A ^a   Sallenave, Jean Michel ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

1 Antitrypsin; Atherosclerosis; Elafin; Human neutrophil elastase

Indexed keywords

ALPHA 1 ANTITRYPSIN; ELAFIN; LEUKOCYTE ELASTASE; LEUKOCYTE ELASTASE INHIBITOR; MATRIX METALLOPROTEINASE; PROTEINASE INHIBITOR;

ACUTE CORONARY SYNDROME; ANEURYSM RUPTURE; ARTERY INTIMA; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CELL INTERACTION; CORONARY ARTERY ATHEROSCLEROSIS; DEGRANULATION; ENDOTHELIUM INJURY; ENZYMATIC DEGRADATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; PATHOGENESIS; PROTEIN BINDING; SHORT SURVEY;

ALPHA 1-ANTITRYPSIN; ATHEROSCLEROSIS; ELAFIN; HUMANS; LEUKOCYTE ELASTASE; MODELS, BIOLOGICAL;

EID: 43049166916     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.01.004     Document Type: Short Survey

References (40)

1. Baldus S., Eiserich J.P., Mani A., Castro L., Figueroa M., Chumley P., et al. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J. Clin. Invest. 108 12 (2001) 1759-1770
2. Barolet A.W., Nili N., Cheema A., Robinson R., Natarajan M.K., O'Blenes S., et al. Arterial elastase activity after balloon angioplasty and effects of elafin, an elastase inhibitor. Arterioscler. Thromb. Vasc. Biol. 21 8 (2001) 1269-1274
3. Belaaouaj A., McCarthy R., Baumann M., Gao Z., Ley T.J., Abraham S.N., et al. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat. Med. 4 5 (1998) 615-618
4. Boudier C., and Bieth J.G. Oxidized mucus proteinase inhibitor: a fairly potent neutrophil elastase inhibitor. Biochem. J. 303 Pt 1 (1994) 61-68
5. Buffon A., Biasucci L.M., Liuzzo G., D'Onofrio G., Crea F., and Maseri A. Widespread coronary inflammation in unstable angina. N. Engl. J. Med. 347 1 (2002) 5-12
6. Chakraborti S., Mandal M., Das S., Mandal A., and Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol. Cell Biochem. 253 1/2 (2003) 269-285 [review]
7. Cowan B., Baron O., Crack J., Coulber C., Wilson G.J., and Rabinovitch M. Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits after heterotopic cardiac transplantation. J. Clin. Invest. 97 11 (1996) 2452-2468
8. Daugherty A., Dunn J.L., Rateri D.L., and Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94 1 (1994) 437-444
9. Dinerman J.L., Mehta J.L., Saldeen T.G., Emerson S., Wallin R., Davda R., et al. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J. Am. Coll. Cardiol. 15 7 (1990) 1559-1563
10. Dollery C.M., Owen C.A., Sukhova G.K., Krettek A., Shapiro S.D., and Libby P. Neutrophil elastase in human atherosclerotic plaques: production by macrophages. Circulation 107 22 (2003) 2829-2836
11. Duboscq C., Genoud V., Parborell M.F., and Kordich L.C. Impaired clot lysis by rt-PA catalyzed mini-plasminogen activation. Thromb. Res. 86 6 (1997) 505-513
12. Fontaine V., Touat Z., Mtairag E.M., Vranckx R., Louedec L., Houard X., et al. Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. Am. J. Pathol. 164 6 (2004) 2077-2087
13. Gacko M., and Glowinski S. Activities of proteases in parietal thrombus of aortic aneurysm. Clin. Chim. Acta 271 2 (1998) 171-177
14. Ganaha F., Ohashi K., Do Y.S., Lee J., Sugimoto K., Minamiguchi H., et al. Efficient inhibition of in-stent restenosis by controlled stent-based inhibition of elastase: a pilot study. J. Vasc. Interv. Radiol. 15 11 (2004) 1287-1293
15. Garcia-Touchard A., Henry T.D., Sangiorgi G., Spagnoli L.G., Mauriello A., Conover C., et al. Extracellular proteases in atherosclerosis and restenosis. Arterioscler. Thromb. Vasc. Biol. 25 6 (2005) 1119-1127 [review]
16. Henriksen P.A., Hitt M., Xing Z., Wang J., Haslett C., Riemersema R.A., et al. Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-kappa B-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli. J. Immunol. 172 7 (2004) 4535-4544
17. Houard X., Leclercq A., Fontaine V.M., Coutard M., Martin-Ventura J.L., Ho-Tin-Noe B., et al. Retention and activation of blood-borne proteases in the arterial wall. J. Am. Coll. Cardiol. 9 Suppl. A (2006) A3-A9 [review]
18. Houghton A.M., Quintero P.A., Perkins D.L., Kobayashi D.K., Kelley D.G., Marconcini L.A., et al. Elastin fragments drive disease progression in a murine model of emphysema. J. Clin. Invest. 116 3 (2006) 753-759
19. Leclercq A., Houard X., Philippe M., Ollivier V., Sebbag U., Meilhac O., et al. Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J. Leukoc. Biol. 82 (2007) 1-10
20. Lee W.L., and Downey G.P. Leukocyte elastase: physiological functions and role in acute lung injury. Am. J. Respir. Crit. Care Med. 164 5 (2001) 896-904 [review]
21. Mashiba S., Wada Y., Takeya M., Sugiyama A., Hamakubo T., Nakamura A., et al. In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL. Arterioscler. Thromb. Vasc. Biol. 21 11 (2001) 1801-1808
22. Mtairag E.M., Houard X., Rais S., Pasquier C., Oudghiri M., Jacob M.P., et al. Pharmacological potentiation of natriuretic peptide limits polymorphonuclear neutrophil-vascular cell interactions. Arterioscler. Thromb. Vasc. Biol. 22 11 (2002) 1824-1831
23. Naruko T., Ueda M., Haze K., van der Wal A.C., van der Loos C.M., Itoh A., et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106 23 (2002) 2894-2900
24. O'Blenes S.B., Zaidi S.H., Cheah A.Y., McIntyre B., Kaneda Y., and Rabinovitch M. Gene transfer of the serine elastase inhibitor elafin protects against vein graft degeneration. Circulation 102 19 Suppl. 3 (2000) III289-III295
25. Ohta K., Nakajima T., Cheah A.Y., Zaidi S.H., Kaviani N., Dawood F., et al. Elafin-overexpressing mice have improved cardiac function after myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 287 1 (2004) H286-H292
26. Okada Y., and Nakanishi I. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G. FEBS Lett. 249 2 (1989) 353-356
27. Okada Y., Watanabe S., Nakanishi I., Kishi J., Hayakawa T., Watorek W., et al. Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett. 229 1 (1988) 157-160
28. Robert L., Robert A.M., and Jacotot B. Elastin-elastase-atherosclerosis revisited. Atherosclerosis 140 2 (1998) 281-295 [review]
29. Shapiro S.D. Neutrophil elastase: path clearer, pathogen killer, or just pathologic?. Am. J. Respir. Cell Mol. Biol. 26 3 (2002) 266-268 [review]
30. Shapiro S.D., Goldstein N.M., Houghton A.M., Kobayashi D.K., Kelley D., and Belaaouaj A. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am. J. Pathol. 163 6 (2003) 2329-2335
31. Sires U.I., Murphy G., Baragi V.M., Filszar C.J., Welgus H.G., and Senior R.M. Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of alpha-1-antirypsin. Biochem. Biophys. Res. Commun. 204 2 (1994) 613-620
32. Smith F.B., Fowkes F.G., Rumley A., Lee A.J., Lowe G.D., and Hau C.M. Tissue plasminogen activator and leucocyte elastase as predictors of cardiovascular events in subjects with angina pectoris: Edinburgh Artery Study. Eur. Heart J. 21 19 (2000) 1607-1613
33. Sumi Y., Inoue N., Azumi H., Seno T., Okuda M., Hirata K., et al. Expression of tissue transglutaminase and elafin in human coronary artery: implication for plaque instability. Atherosclerosis 160 1 (2002) 31-39
34. Taggart C., Cervantes-Laurean D., Kim G., McElvaney N.G., Wehr N., Moss J., et al. Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J. Biol. Chem. 275 35 (2000) 27258-27265
35. Talmud P.J., Martin S., Steiner G., Flavell D.M., Whitehouse D.B., Nagl S., et al. Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene. Arterioscler. Thromb. Vasc. Biol. 23 4 (2003) 644-649
36. Westlin W.F., and Gimbrone Jr. M.A. Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation. Am. J. Pathol. 142 1 (1993) 117-128
37. Williams S.E., Brown T.I., Roghanian A., and Sallenave J.M. SLPI and elafin: one glove, many fingers. Clin. Sci. (Lond.) 110 1 (2006) 21-35 [review]
38. Wu K., Urano T., Ihara H., Takada Y., Fujie M., Shikimori M., et al. The cleavage and inactivation of plasminogen activator inhibitor type 1 by neutrophil elastase: the evaluation of its physiologic relevance in fibrinolysis. Blood 86 3 (1995) 1056-1061
39. Zaidi S.H., You X.M., Ciura S., O'Blenes S., Husain M., and Rabinovitch M. Suppressed smooth muscle proliferation and inflammatory cell invasion after arterial injury in elafin-overexpressing mice. J. Clin. Invest. 105 12 (2000) 1687-1695
40. Zaidi S.H., You X.M., Ciura S., You X.M., Husain M., and Rabinovitch M. Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension. Circulation 105 4 (2002) 516-521